Scinovex
reviewTop 1% cited

Macrophage phenotypes in atherosclerosis

Immunological Reviews · 2014 · Vol. 262(1) · pp. 153–166
Sophie ColinGiulia ChinettiBart Staels

Abstract

Initiation and progression of atherosclerosis depend on local inflammation and accumulation of lipids in the vascular wall. Although many cells are involved in the development and progression of atherosclerosis, macrophages are fundamental contributors. For nearly a decade, the phenotypic heterogeneity and plasticity of macrophages has been studied. In atherosclerotic lesions, macrophages are submitted to a large variety of micro-environmental signals, such as oxidized lipids and cytokines, which influence the phenotypic polarization and activation of macrophages resulting in a dynamic plasticity. The macrophage phenotype spectrum is characterized, at the extremes, by the classical M1 macrophages induced by T-helper 1 (Th-1) cytokines and by the alternative M2 macrophages induced by Th-2 cytokines. M2 macrophages can be further classified into M2a, M2b, M2c, and M2d subtypes. More recently, additional plaque-specific macrophage phenotypes have been identified, termed as Mox, Mhem, and M4. Understanding the mechanisms and functional consequences of the phenotypic heterogeneity of macrophages will contribute to determine their potential role in lesion development and plaque stability. Furthermore, research on macrophage plasticity could lead to novel therapeutic approaches to counteract cardiovascular diseases such as atherosclerosis. The present review summarizes our current knowledge on macrophage subsets in atherosclerotic plaques and mechanism behind the modulation of the macrophage phenotype.

Immune cells in cancerAdipokines, Inflammation, and Metabolic DiseasesAtherosclerosis and Cardiovascular DiseasesPhenotypeMacrophageMacrophage polarizationBiologyInflammationImmunologyPhenotypic plasticityProinflammatory cytokineM2 MacrophageImmune system

MeSH terms

AnimalsCell MovementHumansMacrophage ActivationMacrophagesPhenotypeTranscription FactorsAtherosclerosisPlaque, Atherosclerotic

Funding

  • Institut Universitaire de France
Citations
640
FWCI
14.79
field-weighted impact
References
166
Percentile
99%
vs. same field & year
Citations per year
References
Causes and consequences of microRNA dysregulation in cancer
Nature Reviews Genetics · 2009 · 3,006 citations
The many faces of macrophage activation
Journal of Leukocyte Biology · 2003 · 1,887 citations
Alternative activation of macrophages
Nature reviews. Immunology · 2003 · 6,118 citations
Exploring the full spectrum of macrophage activation
Nature reviews. Immunology · 2008 · 8,962 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.